PEA
PEA
Palmitoylethanolamide is a potent anti-inflammatory that supports a healthy immune system and has neuroprotective properties for brain health and cognitive function.
Helps immunity & manage pain
Free Shipping in 72h | Money back guarantee
Benefits
Benefits
Ingredients
Ingredients
How PEA works?
How PEA works?
How should PEA be taken?
How should PEA be taken?
Shipping
Shipping
Shipping is free across Europe.
Delivery time:
2-3 working days for Germany, Spain, United Kingdom, France and Italy.
5-6 working days for: Austria, Belgium, Bulgaria, Croatia, Cyprus, Chech Republic, Denmark, Estonia, Finland, Greece, Hungary, Ireland, Latvia, Lithuania, Luxembourg, Malta, Netherlands, Poland, Portugal, Romania, Slovakia, Slovenia.
Why Subscribe
Why Subscribe
Our products are meant to be taken long-term in order to get the full benefits. Subscriptions simplify the process and guarantee you always have access.
Pain Management
Allergy Management
Muscle Strength and Hyperthrophy
Immune Enhancement
Brain Function
1. Lang-Illievich K, Klivinyi C, Lasser C, Brenna C, Szilagyi I, Bornemann-Cimenti H. Palmitoylethanolamide in the Treatment of Chronic Pain: A Systematic Review and Meta-Analysis of Double-Blind Randomized Controlled Trials. Nutrients. 2023 Mar; 16(6): 1350.
2. Artikoglu B, Beyer C, Zuloff-Shani A, Brener E, Bloch M. Efficacy of Palmitoylethanolamide for Pain: A Meta-Analysis. Pain Phys. 2017 Jul; 20(5): 353-362.
3. Di Nardo G, Bernardo L, Cremon C, Barbara G, Felici E, Evangelisti M, et al. Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial. Nutrition. 2024 Jun; 122: 112397.
4. Cremon C, Stanghellini V, et al. Randomised clinical trial: the analgesic properties of dietary supplementation with palmitoylethanolamide and polydatin in irritable bowel syndrome. Aliment Pharmacol Ther. 2017 Apr; 45(7): 909-922.
5. Briskey D, Skinner R, Smith C, Rao A. Effectiveness of PE (Levagen+) Compared to a Placebo for Reducing Pain, Duration, and Medication Use during Migraines in Otherwise Healthy Participants-A Double-Blind Randomised Controlled Study. Pharmaceuticals (Basel). 2024 Jan; 17(2): 145.
6. Pickering E, Steels E, Steadman K, Rao A, Vitetta L. A randomized controlled trial assessing the safety and efficacy of palmitoylethanolamide for treating diabetic-related peripheral neuropathic pain. Inflammopharmacology. 2022 Dec; 30(6): 2063-2077.
7. Cruccu G, Di Stefano G, Marchettini P, Truini A. Micronized Palmitoylethanolamide: A Post Hoc Analysis of a Controlled Study in Patients with Low Back Pain – Sciatica. CNS Neurol Disord Drug Targets. 2019 Aug; 18(6): 491-495.
8. Steels E, Vankatesh R, Steels E, Vitetta G, Vitetta L. A double-blind randomized placebo controlled study assessing safety, tolerability and efficacy of palmitoylethanolamide for symptoms of knee osteoarthritis. Inflammopharmacology. 2019 Jun; 27(3): 475-485.
9. Shekhar A, Srivastava A, Verma N, Verma A, Chaturvedi T. The Comparative Efficacy of Palmitoylethanolamide (PEA) With the Combination of Pregabalin and Nortriptyline on Post-extraction Trigeminal Neuropathy by Using Magnetic Resonance (MR) Neurography: A Randomized Clinical Trial. Cureus. 2024 Feb; 16(2): e54843.
10. Briskey D, Ebelt P, Rao A. The Effect of Levagen+ (Palmitoylethanolamide) Supplementation on Symptoms of Allergic Rhinitis—A Double-Blind Placebo-Controlled Trial. Nutrients. 2023 Nov; 15(23): 4940.
11. Kim N, Parolin B, Renshaw D, Deb S, Zariwala M. Formulated Palmitoylethanolamide Supplementation Improves Parameters of Cognitive Function and BDNF Levels in Young, Healthy Adults: A Randomised Cross-Over Trial. Nutrients. 2024 Feb; 16(4): 489.
12. Huschtscha Z, Silver J, Gerhardy M, Urwin C, Kenney N, Le V, et al. The Effect of Palmitoylethanolamide (PEA) on Skeletal Muscle Hypertrophy, Strength, and Power in Response to Resistance Training in Healthy Active Adults: A Double-Blind Randomized Control Trial. Sports Med Open. 2024 Jun; 10: 66.
13. Fessler S, Liu L, Chang Y, Yip T, Johnston C. Palmitoylethanolamide Reduces Proinflammatory Markers in Unvaccinated Adults Recently Diagnosed with COVID-19: A Randomized Controlled Trial. J Nutr. 2022 Oct; 152(10): 2218-2226.
14. Rao A, Skinner R, Briskey D. The Efficacy of Palmitoylethanolamide (Levagen+) on the Incidence and Symptoms of Upper Respiratory Tract Infection-A Double Blind, Randomised, Placebo-Controlled Trial. Nutrients. 2023 Oct; 15(20): 4453.
The NULLURE Promise
Innovative Formulations
Based on the latest scientific, peer-reviewed, research. Optimised dose, absorption and effectiveness.
Independent Third-Party Testing
Guaranteeing the potency and purity of our formulas.
Clean formulas
Free from harmful fillers, artificial additives, and unnecessary preservatives.
Carefully Manufactured in Barcelona
in small batches under the strictest European restrictions of excellence
Science-backed ingredients
Our ingredients are standardized and tested to guarantee their active compound levels. We choose the most bioavailable and biologically active ingredient forms. Whenever possible, we source the best in class patented and fully traceable ingredients.
Palmitoylethanolamide (PEA)
Our ingredients are standardized and tested to guarantee their active compound levels. We choose the most bioavailable and biologically active ingredient forms. Whenever possible, we source the best in class patented and fully traceable ingredients.